NeuroOne Medical Technologies Corporation (NMTC)
NASDAQ: NMTC · Real-Time Price · USD
0.7512
-0.0373 (-4.73%)
At close: Mar 13, 2026, 4:00 PM EDT
0.7700
+0.0188 (2.50%)
After-hours: Mar 13, 2026, 6:36 PM EDT
NMTC Revenue
NeuroOne Medical Technologies had revenue of $2.89M in the quarter ending December 31, 2025, a decrease of -53.90%. This brings the company's revenue in the last twelve months to $8.72M, down -0.38% year-over-year. In the fiscal year ending September 30, 2025, NeuroOne Medical Technologies had annual revenue of $12.10M with 250.35% growth.
Revenue (ttm)
$8.72M
Revenue Growth
-0.38%
P/S Ratio
3.24
Revenue / Employee
$650,898
Employees
18
Market Cap
37.96M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | 12.10M | 8.64M | 250.35% |
| Sep 30, 2024 | 3.45M | 45.37K | 1.33% |
| Sep 30, 2023 | 3.41M | 1.29M | 60.73% |
| Sep 30, 2022 | 2.12M | 1.88M | 772.60% |
| Sep 30, 2021 | 242.96K | -1.68M | -87.39% |
| Sep 30, 2020 | 1.93M | - | - |
| Sep 30, 2019 | - | - | - |
| Sep 30, 2018 | - | - | - |
| Jun 30, 2018 | - | - | - |
| Dec 31, 2017 | - | - | - |
| Sep 30, 2017 | - | - | - |
| Dec 31, 2016 | - | - | - |
| Sep 30, 2016 | - | - | - |
| Dec 31, 2015 | - | - | - |
| Sep 30, 2015 | -113.00 | -886.00 | - |
| Dec 31, 2014 | 773.00 | -476.00 | -38.11% |
| Dec 31, 2013 | 1.25K | 328.00 | 35.61% |
| Dec 31, 2012 | 921.00 | -4.48K | -82.94% |
| Dec 31, 2011 | 5.40K | 4.23K | 362.55% |
| Dec 31, 2010 | 1.17K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Accuray | 436.97M |
| Nortech Systems | 116.67M |
| TELA Bio | 77.06M |
| Myomo | 40.93M |
| Cytosorbents | 36.98M |
| electroCore | 29.84M |
| Spectral AI | 23.17M |
| Elutia | 12.29M |
NMTC News
- 2 days ago - NeuroOne Medical Technologies Corporation (NMTC) Discusses Platform Technology Advancements and Growth Plans for Neurological Device Applications Transcript - Seeking Alpha
- 26 days ago - NeuroOne Medical Technologies Corporation (NMTC) Q1 2026 Earnings Call Transcript - Seeking Alpha
- 3 months ago - NeuroOne Medical Technologies Corporation (NMTC) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 5 months ago - NeuroOne Medical Technologies Corporation - Special Call - Seeking Alpha
- 6 months ago - NeuroOne® to Participate in Sidoti Small-Cap Conference on September 17th and 18th, 2025 - GlobeNewsWire
- 7 months ago - NeuroOne® Receives FDA 510(k) Clearance for OneRF® Trigeminal Nerve Ablation System to Treat Facial Pain - GlobeNewsWire
- 7 months ago - NeuroOne Medical Technologies Corporation (NMTC) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 7 months ago - NeuroOne® Reports Third Quarter Fiscal Year 2025 Financial Results; Revenue Increases 105% YoY and Gross Margin Expands to 53.9% - GlobeNewsWire